Combination Treatment for Moderate to Severe Acne
Sponsored by Medicis Global Service Corporation
About this trial
Last updated 14 years ago
Study ID
MP-0104-28
Status
Completed
Type
Interventional
Phase
Phase 4
Placebo
No
Accepting
12 to 30 Years
All
Trial Timing
Ended 14 years ago
What is this trial about?
To determine if a combination of three currently approved acne products are safe and
effective for the treatment of moderate to severe acne
What are the participation requirements?
Inclusion Criteria
- moderate to severe acne, IGA = 3 or 4 (Investigator Global Assessment)
Exclusion Criteria
- pregnancy and allergies